Legal Opinion
United States ex rel. Bergman v. Abbot Laboratories
District Court, E.D. Pennsylvania
Decided January 30, 2014No. Civil Action No. 09-4264PublishedCited by 15 opinions
1Opinion of the Court
MEMORANDUM
JONES, II, District Judge.
I. BACKGROUND
Qui tam Relator Amy Bergman (“Relator”) brings this action against Abbott Laboratories (“Defendant”) under the False Claims Act (FCA), 31 U.S.C. § 3729 et seq., and similar state statutes. First Amended Complaint (“AC”) (Dkt. No. 18) ¶¶ 1-2. Specifically, Relator alleges that Defendant falsely and misleadingly marketed its prescription drug TriCor for off-label and medically unnecessary uses, and knowingly paid illegal kickbacks to physicians, thereby causing the submission of false claims to government healthcare systems, including Medicare,…
2Cases cited74 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
- Fowler v. UPMC SHADYSIDECourt of Appeals for the Third Circuit · 2009
- Gertz v. Robert Welch, Inc.Supreme Court of the United States · 1974
69 more not listed; retrieve them via the Exa API.
3Cited by15 opinions
- Jones-McNamara v. Holzer Health SystemsCourt of Appeals for the Sixth Circuit · 2015
- United States ex rel. Bilotta v. Novartis Pharmaceuticals Corp.District Court, S.D. New York · 2014
- Kane v. Healthfirst, Inc.District Court, S.D. New York · 2015
- Weslowski v. ZugibeDistrict Court, S.D. New York · 2014
- Temple-Inland, Inc. v. CookDistrict Court, D. Delaware · 2016
10 more not listed; retrieve them via the Exa API.